Neoadjuvant dual checkpoint inhibition followed by immune-chemoradiation in patients with resectable gastric adenocarcinoma

被引：0
|
作者：
Pabon, Cindy M.
Xiao, Lianchun
Badgwell, Brian D.
Mansfield, Paul F.
Ikoma, Naruhiko
Sewastjanow-Silva, Matheus
Lee, Jeffrey H.
Bhutani, Manoop S.
Weston, Brian
Coronel, Emmanuel
Smith, Grace L.
Holliday, Emma
Tian, Jessie
Das, Prajnan
Minsky, Bruce D.
Waters, Rebecca E.
Estrella, Jeannelyn
Li, Jenny Jing
Ajani, Jaffer A.
Murphy, Mariela A. Blum
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Radiat Oncol, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Gastrointestinal Med Oncol, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4067
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Margin status and neoadjuvant chemoradiation in patients with borderline resectable pancreatic cancer
    Papavasiliou, Pavlos
    Piposar, Jonathan R.
    Arrangoiz, Rodrigo
    Chen, Kathryn T.
    Zhu, Fang
    Chun, Yun Shin
    Hoffman, John Parker
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [42] Maximizing the Effect of Neoadjuvant Chemoradiation in Patients with Borderline Resectable Pancreatic Cancer
    Sopka, D. M.
    Chun, Y. S.
    Cohen, S. J.
    Zhu, F.
    Milestone, B. N.
    Cooper, H. S.
    Freedman, G. M.
    Burtness, B. A.
    Hoffman, J. P.
    Meyer, J. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S335 - S335
  • [43] The Effect of Fiducials on Resection Margin and Nodal Disease in Patients Receiving Neoadjuvant Chemoradiation Therapy for Borderline Resectable Pancreatic Adenocarcinoma
    Kumar, Ujjala
    Garg, Mrinal
    Sharma, Manav
    Gulati, Abhishek
    Kulkarni, Abhijit
    Dhawan, Manish
    Kirichenko, Alexander
    Morrissey, Suzanne
    Monga, Dulabh
    Atkinson, Donald
    Schiffman, Suzanne
    Williams, Harry
    Maheshwary, Rishi
    Mitre, Marcia
    Thakkar, Shyam
    GASTROENTEROLOGY, 2016, 150 (04) : S322 - S322
  • [44] Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)
    Van Heijl M.
    Van Lanschot J.J.B.
    Koppert L.B.
    Van Berge Henegouwen M.I.
    Muller K.
    Steyerberg E.W.
    Van Dekken H.
    Wijnhoven B.P.L.
    Tilanus H.W.
    Richel D.J.
    Busch O.R.C.
    Bartelsman J.F.
    Koning C.C.E.
    Offerhaus G.J.
    Van Der Gaast A.
    BMC Surgery, 8 (1)
  • [45] Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Crane, Christopher H.
    Sun, Charlotte C.
    Lee, Jeffrey E.
    Pisters, Peter W. T.
    Vauthey, Jean-Nicolas
    Abdalla, Eddie
    Wang, Huamin
    Staerkel, Gregg A.
    Lee, Jeffrey H.
    Ross, William A.
    Tamm, Eric P.
    Bhosale, Priya R.
    Krishnan, Sunil
    Das, Prajnan
    Ho, Linus
    Xiong, Henry
    Abbruzzese, James L.
    Evans, Douglas B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3487 - 3495
  • [46] Adding immune checkpoint blockade to neoadjuvant chemoradiation in locally advanced rectal cancer
    Pang, Kai
    Yang, Yun
    Zhao, Pengfei
    Wu, Guocong
    Li, Jun
    Gao, Jiale
    Yao, Hongwei
    Yang, Yingchi
    Zhang, Zhongtao
    BRITISH JOURNAL OF SURGERY, 2022, 109 (11) : 1178 - 1179
  • [47] A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC
    Lemmon, Christopher A.
    Videtic, Gregory M. M.
    Murthy, Sudish
    Stephans, Kevin L.
    Shapiro, Marc
    Ahmad, Usman
    Raymond, Daniel
    Velcheti, Vamsidhar
    Bribriesco, Alejandro
    Jia, Xuefei
    Stevenson, James
    Pennell, Nathan A.
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (07):
  • [48] Efficacy of Three-Drug Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Localized Gastric Adenocarcinoma
    Mizrak Kaya, Dilsa
    Nogueras Gonzalez, Graciela M.
    Harada, Kazuto
    Blum Murphy, Mariela A.
    Lee, Jeffrey H.
    Bhutani, Manoop S.
    Weston, Brian
    Thomas, Irene
    Rogers, Jane E.
    Das, Prajnan
    Badgwell, Brian D.
    Ajani, Jaffer A.
    ONCOLOGY, 2020, 98 (08) : 542 - 548
  • [49] Concurrent versus sequential immune checkpoint inhibition in stage III NSCLC patients treated with chemoradiation
    Kaesmann, L.
    Taugner, J.
    Eze, C.
    Guggenberger, J.
    Floesch, B.
    Kenndoff, S.
    Tufman, A.
    Reinmuth, N.
    Belka, C.
    Manapov, F.
    ANNALS OF ONCOLOGY, 2022, 33 : S86 - S86
  • [50] Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
    Bao, Yongxing
    Wang, Yang
    Hui, Zhouguang
    THORACIC CANCER, 2022, 13 (21) : 3101 - 3101
12345